These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27274770)

  • 1. Are the physicochemical properties of antibacterial compounds really different from other drugs?
    Ebejer JP; Charlton MH; Finn PW
    J Cheminform; 2016; 8():30. PubMed ID: 27274770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between target-class and the physicochemical properties of antibacterial drugs.
    Mugumbate G; Overington JP
    Bioorg Med Chem; 2015 Aug; 23(16):5218-24. PubMed ID: 25975639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends and exceptions of physical properties on antibacterial activity for Gram-positive and Gram-negative pathogens.
    Brown DG; May-Dracka TL; Gagnon MM; Tommasi R
    J Med Chem; 2014 Dec; 57(23):10144-61. PubMed ID: 25402200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Antibacterial Compounds and their Drug Targets - Successes and Challenges.
    Kaczor AA; Polski A; Sobótka-Polska K; Pachuta-Stec A; Makarska-Bialokoz M; Pitucha M
    Curr Med Chem; 2017; 24(18):1948-1982. PubMed ID: 27978802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and Discovery of New Antibacterial Agents: Advances, Perspectives, Challenges.
    Jampilek J
    Curr Med Chem; 2018; 25(38):4972-5006. PubMed ID: 28925868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QSAR classification model for antibacterial compounds and its use in virtual screening.
    Singh N; Chaudhury S; Liu R; AbdulHameed MD; Tawa G; Wallqvist A
    J Chem Inf Model; 2012 Oct; 52(10):2559-69. PubMed ID: 23013546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Small-molecule Antibacterials against Gram-positive Pathogens of
    Seethaler M; Hertlein T; Wecklein B; Ymeraj A; Ohlsen K; Lalk M; Hilgeroth A
    Antibiotics (Basel); 2019 Nov; 8(4):. PubMed ID: 31684039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety.
    Meanwell NA
    Chem Res Toxicol; 2011 Sep; 24(9):1420-56. PubMed ID: 21790149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient Synthesis and Antibacterial Profile of Bis(2-hydroxynaphthalene- 1,4-dione).
    Novais JS; Rosandiski AC; de Carvalho CM; de Saules Silva LS; Dos S Velasco de Souza LC; Santana MV; Martins NRC; Castro HC; Ferreira VF; Gonzaga DTG; de Resende GO; de C da Silva F
    Curr Top Med Chem; 2020; 20(2):121-131. PubMed ID: 31820692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, Synthesis and Qualitative Structure Activity Relationship Evaluations of Quinoline-Based Bisarylimidazoles as Antibacterial Motifs.
    Al-Qawasmeh RA; Huthail BB; Sinnokrot MO; Semreen MH; Odeh RA; Abu-Zarga MH; Tarazi H; Yousef IA; Al-Tel TH
    Med Chem; 2016; 12(6):563-73. PubMed ID: 27188185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Wound Healing and Antibacterial Activity of Five Ethnomedical Calophyllum inophyllum Oils: An Alternative Therapeutic Strategy to Treat Infected Wounds.
    Léguillier T; Lecsö-Bornet M; Lémus C; Rousseau-Ralliard D; Lebouvier N; Hnawia E; Nour M; Aalbersberg W; Ghazi K; Raharivelomanana P; Rat P
    PLoS One; 2015; 10(9):e0138602. PubMed ID: 26406588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening of antibacterial compounds with novel structure from the FDA approved drugs using machine learning methods.
    Li WX; Tong X; Yang PP; Zheng Y; Liang JH; Li GH; Liu D; Guan DG; Dai SX
    Aging (Albany NY); 2022 Feb; 14(3):1448-1472. PubMed ID: 35150482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular inflation, attrition and the rule of five.
    Leeson PD
    Adv Drug Deliv Rev; 2016 Jun; 101():22-33. PubMed ID: 26836397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, antibacterial, antioxidant activity and QSAR studies of novel 2-arylidenehydrazinyl-4-arylthiazole analogues.
    Alam MS; Ahmed JU; Lee DU
    Chem Pharm Bull (Tokyo); 2014; 62(12):1259-68. PubMed ID: 25450634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New strategies for antibacterial drug design: targeting non-multiplying latent bacteria.
    Coates AR; Hu Y
    Drugs R D; 2006; 7(3):133-51. PubMed ID: 16752940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysine-Based Small Molecules That Disrupt Biofilms and Kill both Actively Growing Planktonic and Nondividing Stationary Phase Bacteria.
    Konai MM; Haldar J
    ACS Infect Dis; 2015 Oct; 1(10):469-78. PubMed ID: 27623313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-likeness and increased hydrophobicity of commercially available compound libraries for drug screening.
    Zuegg J; Cooper MA
    Curr Top Med Chem; 2012; 12(14):1500-13. PubMed ID: 22827520
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.